By VETTAPHARMA reporter – Derek Roche: Moderna, Inc. (Nasdaq: MRNA) announced its participation in two upcoming investor conferences scheduled for March 2026, where company representatives will provide updates to the investment community.
The company will present at the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026, at 1:50 p.m. ET, followed by participation in the Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026, at 9:30 a.m. ET.
A live webcast of each presentation will be available under the “Events and Presentations” section in the Investors area of Moderna’s website at investors.modernatx.com. Replays of both webcasts will be archived on the company’s website for at least 30 days following each presentation.
About Moderna
Moderna is a biotechnology company focused on messenger RNA (mRNA) medicines. Since its founding, the company’s mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, and rare diseases.
Moderna stated that its mission is to deliver the greatest possible impact to people through mRNA medicines, supported by a global team and a culture centered on innovation and scientific advancement.
